Literature DB >> 8011677

Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions.

S A Karabina1, T A Liapikos, G Grekas, J Goudevenos, A D Tselepis.   

Abstract

The distribution of PAF-acetylhydrolase (PAF-AH) activity in 3 LDL subfractions prepared by density gradient ultracentrifugation as well as the rate of phosphatidylcholine (PC) hydrolysis during oxidation was studied. PAF-AH activity, measured before oxidation, was much higher in LDL3 subfraction (28.4 +/- 8.6 nmol/mg per min) comparing to LDL2 (14.1 +/- 5.8 nmol/mg per min), and to LDL1, 8.7 +/- 3.7 nmol/mg per min. During oxidation, the enzyme activity was continuously decreased and this phenomenon was more pronounced in LDL1. PC hydrolysis was studied measuring the lyso-PC production expressed as lyso-PC/Sph molar ratio. Before oxidation, the lyso-PC/Sph molar ratio, did not differ significantly among the LDL subfractions, whereas, 4 h after the onset of oxidation, it was significantly higher in LDL2 and LDL3 subfractions (0.42 +/- 0.12 and 0.45 +/- 0.10, respectively), comparing to LDL1 (0.29 +/- 0.06). Our results show that the distribution of PAF-AH activity in LDL subfractions is heterogeneous (mainly distributed in LDL2 and LDL3 subfractions) and it is positively correlated with higher lyso-PC production in those subfractions during oxidation. The contribution of this phenomenon to the enhanced susceptibility to oxidation as well as to the higher atherogenicity of the dense LDL subfractions is under investigation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011677     DOI: 10.1016/0005-2760(94)90219-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Short-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants.

Authors:  Alexander K Tsai; Brian T Steffen; Jose M Ordovas; Robert Straka; Xia Zhou; Naomi Q Hanson; Donna Arnett; Michael Y Tsai
Journal:  Transl Res       Date:  2011-02-26       Impact factor: 7.012

2.  Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with β-thalassemia.

Authors:  Alexandros D Tselepis; George Hahalis; Constantinos C Tellis; Eleni C Papavasiliou; Panagiota T Mylona; Alexandra Kourakli; Dimitrios C Alexopoulos
Journal:  J Lipid Res       Date:  2010-07-12       Impact factor: 5.922

Review 3.  Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.

Authors:  Mohammad Madjid; Muzammil Ali; James T Willerson
Journal:  Tex Heart Inst J       Date:  2010

4.  Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.

Authors:  C H MacPhee; K E Moores; H F Boyd; D Dhanak; R J Ife; C A Leach; D S Leake; K J Milliner; R A Patterson; K E Suckling; D G Tew; D M Hickey
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

Review 5.  The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.

Authors:  Salim S Virani; Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

6.  The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂.

Authors:  Constantinos C Tellis; Eliza Moutzouri; Moses Elisaf; Robert L Wolfert; Alexandros D Tselepis
Journal:  J Lipid Res       Date:  2013-10-03       Impact factor: 5.922

7.  New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis.

Authors:  Michael Y Tsai; Brian T Steffen; Weihua Guan; Robyn L McClelland; Russell Warnick; Joseph McConnell; Daniel M Hoefner; Alan T Remaley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-14       Impact factor: 8.311

8.  Unraveling the PAF-AH/Lp-PLA2 controversy.

Authors:  Diana M Stafforini; Guy A Zimmerman
Journal:  J Lipid Res       Date:  2014-07-09       Impact factor: 5.922

9.  Association of low-density lipoprotein pattern with mortality after myocardial infarction: Insights from the TRIUMPH study.

Authors:  Yashashwi Pokharel; Yuanyuan Tang; Bhaskar Bhardwaj; Krishna K Patel; Mohammed Qintar; James H O'Keefe; Krishnaji R Kulkarni; Peter H Jones; Seth S Martin; Salim S Virani; John A Spertus
Journal:  J Clin Lipidol       Date:  2017-10-03       Impact factor: 4.766

10.  Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.

Authors:  Takeki Suzuki; Cam Solomon; Nancy Swords Jenny; Russell Tracy; Jeanenne J Nelson; Bruce M Psaty; Curt Furberg; Mary Cushman
Journal:  Circ Heart Fail       Date:  2009-06-19       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.